Table 6.

Analysis of factors influencing efficacy in patients with malignant obstructive jaundice undergoing PTCD treatment

Influencing factor	β	S.E.	Wald	P	OR	95% CI
Sex	-1.349	0.899	2.251	0.134	0.259	0.045-1.512
Age (years old)	-0.003	0.869	0.000	0.997	0.997	0.182-5.472
Hospital stay (days)	-0.606	0.914	0.439	0.508	0.546	0.091-3.272
Obstruction site	2.137	0.869	6.055	0.014	8.478	1.545-46.519
Hypertension	0.508	0.859	0.350	0.554	1.622	0.309-8.958
Diabetes	-0.044	1.112	0.002	0.969	0.957	0.108-8.458
Pancreatic malignancy	-0.394	1.259	0.098	0.754	0.674	0.057-7.957
Preoperative biliary tract infection	-1.179	1.570	0.563	0.453	0.308	0014-6.680
Preoperative liver dysfunction	1.740	0.865	4.046	0.044	5.700	1.046-31.072

Note: PTCD, percutaneous transhepatic cholangiography and biliary drainage.